Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Childhood Brain Neoplasm 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Neurodegenerative Diseases 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Brain Neoplasms 1Brain Injuries 1

Interventions

Magnetic Resonance Spectroscopy 2gallium 68 PSMA-11 1Oncolytic Virotherapy 1Itraconazole 1Fluorodeoxyglucose F18 1Ferrosoferric Oxide 1FAPI-46 1Bevacizumab 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Esophageal Neoplasms × Ferrosoferric Oxide × Clear all
NCT02857218 2021-09-16

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡